LinkedIn Network Updates, 12/04/2012

	LinkedIn Network Updates, Nov 27 - Dec 4 Updates from Your Extended Network Connect with them to see what they're up to Matt Boeckeler http://lnkd.in/E6PSsj Analysis: Crusades to repair broken drug R&D one disease at a time It's a well-known problem: Pharma companies' research spending has gone up over the past decade or so without an equivalent increase in new drug approvals. Yet as Bloomberg writes in a feature on the issue, individuals have... Connect with Matt · Comment (1) Rick S. http://lnkd.in/58HAYq Egypt and the Strategic Balance | Stratfor Immediately following the declaration of a cease-fire in Gaza, Egypt was plunged into a massive domestic crisis. Mohammed Morsi, elected in the first presidential election after the fall of Hosni Mubarak, passed a decree that... Connect with Rick · Comment Karan Nagra http://lnkd.in/RCNcTp AstraZeneca buys miRNA know how British-Swedish pharma giant AstraZeneca has inlicenced three miRNA targets from Regulus Therapeutics. Connect with Karan · Comment Keith J Wilson Simple and effective way to create real focus on a key differentiating behaviour. Also acts as a quick litmus test - if this behaviour is being displayed everything else is working. Reminds me of a FTSE20 that has one key metric for H.R - the number of days senior execs spend on L&D/coaching etc... http://lnkd.in/KvVUNz The One-Minute Change That Will Transform Your Company Behavior is the mirror in which everyone shows their image.--GoetheCan a single behavior elevate an entire organization? It can--if it’s the right behavior. Here’s how a simple 1-minute act helped an organization reinforce its... Connect with Keith J · Comment View All Updates
	You are receiving Network Updates emails. Unsubscribe. This email was intended for start292 almar (aasdfsdfsd at AstraZeneca). Learn why we included this. © 2012, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA